• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型胰腺神经内分泌肿瘤转移发光小鼠模型的建立与比较。

Development and comparison of novel bioluminescent mouse models of pancreatic neuroendocrine neoplasm metastasis.

机构信息

Department of Neuroscience and Pharmacology, University of Iowa, 2-570 Bowen Science Building, 51 Newton Road, Iowa City, IA, 52242, USA.

Cancer Biology Graduate Program, University of Iowa, Iowa City, IA, USA.

出版信息

Sci Rep. 2021 May 13;11(1):10252. doi: 10.1038/s41598-021-89866-1.

DOI:10.1038/s41598-021-89866-1
PMID:33986468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8119958/
Abstract

Pancreatic neuroendocrine neoplasms (pNENs) are slow growing cancers of increasing incidence that lack effective treatments once they become metastatic. Unfortunately, nearly half of pNEN patients present with metastatic liver tumors at diagnosis and current therapies fail to improve overall survival. Pre-clinical models of pNEN metastasis are needed to advance our understanding of the mechanisms driving the metastatic process and for the development of novel, targeted therapeutic interventions. To model metastatic dissemination of tumor cells, human pNEN cell lines (BON1 and Qgp1) stably expressing firefly luciferase (luc) were generated and introduced into NSG immunodeficient mice by intracardiac (IC) or intravenous (IV) injection. The efficiency, kinetics and distribution of tumor growth was evaluated weekly by non-invasive bioluminescent imaging (BLI). Tumors formed in all animals in both the IC and IV models. Bioluminescent Qgp1.luc cells preferentially metastasized to the liver regardless of delivery route, mimicking the predominant site of pNEN metastasis in patients. By comparison, BON1.luc cells most commonly formed lung tumors following either IV or IC administration and colonized a wider variety of tissues than Qgp1.luc cells. These models provide a unique platform for testing candidate metastasis genes and anti-metastatic therapies for pNENs.

摘要

胰腺神经内分泌肿瘤(pNENs)是一种生长缓慢、发病率不断上升的癌症,一旦发生转移,目前缺乏有效的治疗方法。不幸的是,近一半的 pNEN 患者在诊断时已出现肝转移瘤,而目前的治疗方法并不能改善总体生存率。需要建立 pNEN 转移的临床前模型,以深入了解驱动转移过程的机制,并开发新的、有针对性的治疗干预措施。为了模拟肿瘤细胞的转移扩散,我们构建了稳定表达萤火虫荧光素酶(luc)的人 pNEN 细胞系(BON1 和 Qgp1),并通过心内(IC)或静脉(IV)注射将其导入 NSG 免疫缺陷小鼠体内。每周通过非侵入性生物发光成像(BLI)评估肿瘤生长的效率、动力学和分布。在 IC 和 IV 模型中,所有动物均形成了肿瘤。无论给药途径如何,生物发光的 Qgp1.luc 细胞均优先转移到肝脏,模拟了患者中 pNEN 转移的主要部位。相比之下,BON1.luc 细胞在 IV 或 IC 给药后最常形成肺肿瘤,并比 Qgp1.luc 细胞定植更广泛的组织。这些模型为测试候选转移基因和针对 pNENs 的抗转移治疗提供了独特的平台。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/369a/8119958/e060f0fe8ea7/41598_2021_89866_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/369a/8119958/de38568d6549/41598_2021_89866_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/369a/8119958/399df1ac9b9c/41598_2021_89866_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/369a/8119958/9edb21bfa754/41598_2021_89866_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/369a/8119958/dc296f6d70a0/41598_2021_89866_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/369a/8119958/e060f0fe8ea7/41598_2021_89866_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/369a/8119958/de38568d6549/41598_2021_89866_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/369a/8119958/399df1ac9b9c/41598_2021_89866_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/369a/8119958/9edb21bfa754/41598_2021_89866_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/369a/8119958/dc296f6d70a0/41598_2021_89866_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/369a/8119958/e060f0fe8ea7/41598_2021_89866_Fig5_HTML.jpg

相似文献

1
Development and comparison of novel bioluminescent mouse models of pancreatic neuroendocrine neoplasm metastasis.新型胰腺神经内分泌肿瘤转移发光小鼠模型的建立与比较。
Sci Rep. 2021 May 13;11(1):10252. doi: 10.1038/s41598-021-89866-1.
2
Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis.生物发光成像(BLI)用于改进和完善传统的肿瘤生长与转移小鼠模型。
Clin Exp Metastasis. 2003;20(8):733-44. doi: 10.1023/b:clin.0000006815.49932.98.
3
Neuropilin-1 (NRP-1) upregulated by IL-6/STAT3 signaling contributes to invasion in pancreatic neuroendocrine neoplasms.白细胞介素 6/STAT3 信号通路上调神经纤毛蛋白-1(NRP-1)促进胰腺神经内分泌肿瘤侵袭。
Hum Pathol. 2018 Nov;81:192-200. doi: 10.1016/j.humpath.2018.06.030. Epub 2018 Jul 3.
4
In vivo monitoring of tumor relapse and metastasis using bioluminescent PC-3M-luc-C6 cells in murine models of human prostate cancer.在人前列腺癌小鼠模型中使用生物发光PC-3M-luc-C6细胞对肿瘤复发和转移进行体内监测。
Clin Exp Metastasis. 2003;20(8):745-56. doi: 10.1023/b:clin.0000006817.25962.87.
5
Bioluminescent human breast cancer cell lines that permit rapid and sensitive in vivo detection of mammary tumors and multiple metastases in immune deficient mice.生物发光人类乳腺癌细胞系,可在免疫缺陷小鼠体内快速、灵敏地检测乳腺肿瘤及多处转移灶。
Breast Cancer Res. 2005;7(4):R444-54. doi: 10.1186/bcr1026. Epub 2005 Apr 8.
6
Optimizing live-animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID-NSG mice.优化活体生物发光成像预测 SCID-NSG 小鼠人前列腺癌异种移植模型中的肿瘤负担。
Prostate. 2019 Jun;79(9):949-960. doi: 10.1002/pros.23802. Epub 2019 Apr 8.
7
Imaging of bioluminescent LNCaP-luc-M6 tumors: a new animal model for the study of metastatic human prostate cancer.生物发光LNCaP-luc-M6肿瘤的成像:一种用于研究转移性人类前列腺癌的新动物模型。
Prostate. 2004 May 15;59(3):292-303. doi: 10.1002/pros.20003.
8
Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis.在一种新的局部肿瘤生长和转移小鼠模型中对人葡萄膜黑色素瘤进行全身生物发光成像。
Invest Ophthalmol Vis Sci. 2005 May;46(5):1581-7. doi: 10.1167/iovs.04-0245.
9
Noninvasive visualization of retinoblastoma growth and metastasis via bioluminescence imaging.通过生物发光成像对视网膜母细胞瘤生长和转移进行无创可视化。
Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5544-51. doi: 10.1167/iovs.08-3258. Epub 2009 Jul 15.
10
The ARF tumor suppressor inhibits tumor cell colonization independent of p53 in a novel mouse model of pancreatic ductal adenocarcinoma metastasis.ARF 肿瘤抑制因子在新型胰腺导管腺癌转移的小鼠模型中独立于 p53 抑制肿瘤细胞定植。
Mol Cancer Res. 2011 Jul;9(7):867-77. doi: 10.1158/1541-7786.MCR-10-0475. Epub 2011 Jun 2.

引用本文的文献

1
Liposomal β-Sitosterol Suppresses Metastasis of CT26/luc Colon Carcinoma via Inhibition of MMP-9 and Evoke of Immune System.脂质体β-谷甾醇通过抑制基质金属蛋白酶-9和激活免疫系统来抑制CT26/luc结肠癌的转移。
Pharmaceutics. 2022 Jun 7;14(6):1214. doi: 10.3390/pharmaceutics14061214.
2
Bacterial bioluminescence assay for bioanalysis and bioimaging.细菌生物发光分析用于生物分析和生物成像。
Anal Bioanal Chem. 2022 Jan;414(1):75-83. doi: 10.1007/s00216-021-03695-9. Epub 2021 Oct 25.
3
Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets.

本文引用的文献

1
Pathological Analysis of Lung Metastasis Following Lateral Tail-Vein Injection of Tumor Cells.经侧尾静脉注射肿瘤细胞后肺转移的病理分析
J Vis Exp. 2020 May 20(159). doi: 10.3791/61270.
2
Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors.基因表达特征可鉴定转移性胰腺神经内分泌肿瘤的新型治疗药物。
Clin Cancer Res. 2020 Apr 15;26(8):2011-2021. doi: 10.1158/1078-0432.CCR-19-2884. Epub 2020 Jan 14.
3
Evaluation and Management of Neuroendocrine Tumors of the Pancreas.胰腺神经内分泌肿瘤的评估和管理。
胰腺神经内分泌肿瘤:分子机制与治疗靶点
Cancers (Basel). 2021 Oct 12;13(20):5117. doi: 10.3390/cancers13205117.
Surg Clin North Am. 2019 Aug;99(4):793-814. doi: 10.1016/j.suc.2019.04.014. Epub 2019 May 27.
4
Two well-differentiated pancreatic neuroendocrine tumor mouse models.两种分化良好的胰腺神经内分泌肿瘤小鼠模型。
Cell Death Differ. 2020 Jan;27(1):269-283. doi: 10.1038/s41418-019-0355-0. Epub 2019 Jun 3.
5
Brain metastases in patients with neuroendocrine neoplasms: risk factors and outcome.神经内分泌肿瘤患者的脑转移:风险因素和结果。
BMC Cancer. 2019 Apr 16;19(1):362. doi: 10.1186/s12885-019-5559-7.
6
Pancreatic neuroendocrine tumours: Grade is superior to T, N, or M status in predicting outcome and selecting patients for chemotherapy:A retrospective cohort study in the SEER database.胰腺神经内分泌肿瘤:在预测结局和选择化疗患者方面,分级优于 T、N 或 M 状态:SEER 数据库中的回顾性队列研究。
Int J Surg. 2019 Jun;66:103-109. doi: 10.1016/j.ijsu.2019.03.006. Epub 2019 Mar 11.
7
Alleles of Insm1 determine whether RIP1-Tag2 mice produce insulinomas or nonfunctioning pancreatic neuroendocrine tumors.Insm1的等位基因决定了RIP1-Tag2小鼠是产生胰岛素瘤还是无功能的胰腺神经内分泌肿瘤。
Oncogenesis. 2019 Feb 22;8(3):16. doi: 10.1038/s41389-019-0127-1.
8
A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant Tumors.患者来源的胰腺神经内分泌肿瘤异种移植模型鉴定沙帕尼塞特布可能是依维莫司耐药肿瘤的新治疗方法。
Mol Cancer Ther. 2018 Dec;17(12):2702-2709. doi: 10.1158/1535-7163.MCT-17-1204. Epub 2018 Sep 25.
9
A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors.神经内分泌肿瘤中机制依赖性的药理学靶向的精准肿瘤学方法。
Nat Genet. 2018 Jul;50(7):979-989. doi: 10.1038/s41588-018-0138-4. Epub 2018 Jun 18.
10
The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines.GEPNET 细胞系的神经内分泌表型、基因组特征和治疗敏感性。
Endocr Relat Cancer. 2018 Mar;25(3):367-380. doi: 10.1530/ERC-17-0445.